Cliintel Capital Management Group (CCMG), the first and currently the only qualified institutional investor capital firm in the United States, is currently raising money for its fifth fund, the “Cannabis Strategic Acquisition Fund, LLC.” CCMG is positioned to control a large portion of the distribution of cannabis in North America through its growth assets and this strategic capital raise.
CCMG has invested in major functions of the cannabis industry to create a vertically integrated ecosystem of captive companies and licensed partners across eight states. Subtle Escape, Bonsai Cultivation and Cannabis Industry Institute are just a few portfolio assets. Many of these
companies are part of the partnership network that help keep their top asset, The Clear, the No. 1 concentrate in the nation. These assets were
acquired, incubated and grown with a blind pool private equity structure allowing investors equity exposure to licensed entities while remaining effectively anonymous.
CCMG’s management group is made up of seasoned executives with more than three decades of expertise in mergers and acquisition, marketing, media, finance, real estate, sales and business intelligence. They have established, acquired, optimized and sold businesses, specializing in rapid-growth mainstream industries.
The minimum investment is $25,000. Accredited investors only; SEC registered.